Assay News and Research

RSS

Missing COVID-19 antibodies suggest mystery immune response

Researchers at Shanghai Public Health Clinical Center have made important discoveries about the immune response among patients who have recovered from mild COVID-19 disease that could help to inform prevention and treatment methods, as well as improve the efficacy of community testing.

13 Apr 2020

Unraveling interactions between metal ions and peptides may lead to new therapies for diseases

Copper ions could play a key role when peptide folding goes wrong and leads to harmful aggregates.

12 Apr 2020

UMSOM launches new initiative to expand COVID-19 testing

University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today the launch of a large-scale COVID-19 Testing Initiative that will significantly expand testing capability over the coming weeks, enabled by new funding of $2.5 million from the State of Maryland.

12 Apr 2020

A Colorado ski community planned to test everyone for COVID-19. Here’s what happened.

In late March, residents of the Colorado town of Telluride and surrounding San Miguel County stood in line, along marked spots spaced 6 feet apart, to have their blood drawn by medical technicians wearing Tyvek suits, face shields and gloves for a new COVID-19 test.

10 Apr 2020

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.

From Avacta Life Sciences Ltd. 9 Apr 2020

World's largest protein connection map reveals cell workings

The human body is comprised of billions of cells. Yet it functions and grows as a single organism, because of trillions of interactions that help various cells recognize and respond to each other via different molecules on their surface or inside the cells. Now, a new study published in the journal Nature in April 2020 describes the first-ever interactome map, to help distinguish healthy interactions and disease-producing ones.

8 Apr 2020

World's largest map of protein connections holds clues to health and disease

Scientists have described the first reference map of interactions between gene-encoded proteins which make up cells.

8 Apr 2020

Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors

Wyatt Technology, the world leader in instrumentation for absolute macromolecular and nanoparticle characterization, announces the release of a novel method suitable for determining multiple critical quality attributes of adeno-associated virus and similar small gene vectors, in a single chromatographic run.

From Waters | Wyatt Technology 8 Apr 2020

New Fleischner Society statement on chest imaging and management of COVID-19 published

A multinational consensus statement from the Fleischner Society on the role of chest imaging in the management of patients with COVID-19 was jointly published today in the journals Radiology and Chest.

7 Apr 2020

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines

Metrion today announced it has contributed to two new peer-reviewed papers under the U.S. FDA CiPA (Comprehensive in vitro Proarrhythmia Assay) initiative.

From Metrion Biosciences Limited 7 Apr 2020

OGT delivers translocation and partial tandem duplication detection with updates to SureSeq NGS portfolio

Oxford Gene Technology announces the addition of accurate detection capabilities for translocations and difficult-to-sequence partial tandem duplications.

From Oxford Gene Technology 7 Apr 2020

UC San Diego Health expands COVID-19 testing capacity

From the beginning, the ability of front line clinicians to test patients for COVID-19 -- to determine whether a person is infected with the disease-causing novel coronavirus, SARS-CoV-2 -- has been part and parcel of the pandemic.

6 Apr 2020

Siemens Healthineers releases test kit for coronavirus COVID-19

Siemens Healthineers announced today the availability of its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.

From Siemens Healthineers Point of Care Diagnostics 6 Apr 2020

Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel

Promega Corporation’s GoTaq Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use.

From Promega Corporation 6 Apr 2020

Trump touted Abbott’s quick COVID-19 test. HHS document shows only 5,500 are on way for entire U.S.

A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.

2 Apr 2020

Nanoneedle technology licensed for early detection of disease, biomarker discovery

A Boston-based startup company, NanoMosaic LLC, intends to commercialize a high-throughput, high-sensitivity platform for analyte detection developed at Harvard University.

2 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

New Vivalytic Viral Respiratory Tract Infection Array can identify SARS-CoV-2 virus

A game-changing point of care coronavirus test from global diagnostics company Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions will launch in April 2020.

From Randox Laboratories Ltd. 1 Apr 2020

Randox partners with government to develop new coronavirus testing program

Randox Laboratories is partnering with the government to develop a new coronavirus testing program in which NHS staff will be first in line.